Tri-phenyl Compounds for Selective Telomerase Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective solutions for enhancing telomerase activity and expression, which is crucial for treating diseases related to telomere length and cellular aging, as existing approaches either promote cancer or lead to premature aging.
Innovation Solution
A series of tri-phenyl compounds represented by specific structures are used to stimulate or increase telomerase activity and expression in cells, potentially treating conditions such as cancer, aging-related diseases, and immune system impairments by administering these compounds to stimulate telomerase activity and expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If telomerase is activated in somatic cells to treat aging-related diseases, then cellular aging is delayed and tissue regeneration is improved, but the risk of cancer development increases due to immortalization of cells
Solution Approach 1:
The patent applies local quality by selectively activating telomerase in specific cell types (progenitor cells, stem cells, immune cells) rather than universally in all somatic cells. This localized activation achieves anti-aging benefits in regenerative tissues while minimizing cancer risk in differentiated cells that should maintain replicative limits.
Solution Approach 2:
The compound acts as an intermediary molecule that indirectly activates telomerase through modulation of cellular signaling pathways rather than directly activating the enzyme. This intermediate mechanism allows for controlled, regulated activation that can be selectively applied to specific cell populations and can be terminated when appropriate.
2Length of stationary object
If existing methods are used to enhance telomerase activity, then telomere length is increased, but harmful effects occur including cancer promotion or premature aging
Solution Approach 1:
The patent changes the parameter of telomerase activation from binary (on/off) to a regulated, dose-dependent process. The compound modulates telomerase activity levels and duration based on cellular context, achieving sufficient telomere maintenance for anti-aging while preventing the excessive activation that leads to cancer.
Solution Approach 2:
The invention introduces dynamic control of telomerase activation through a reversible chemical compound that can be administered, metabolized, and eliminated. This creates a time-dependent activation pattern where telomerase is temporarily enhanced during treatment periods rather than permanently activated, allowing cellular systems to maintain safety mechanisms.
Data Source
AI summary
The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.